Skip to main content

Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine.

Project description

Molecular insight into lymphoma

Complex lymphoproliferative diseases are characterised by the abnormal proliferation of lymphocytes and exhibit clinical aggressiveness as well as low therapeutic response. Information on disease pathogenesis and targeted therapies is scarce due to limited data on predictor markers and poor experimental models. The EU-funded PRECISMEDLYM project focuses on T cell lymphoma that presents a polyclonal profile and exhibits dismal prognosis and frequent relapse. Scientists will investigate the molecular basis of different lymphoma subtypes and identify therapeutic targets through gene expression analysis. This information will be central for patient stratification, supporting precision medicine efforts with reduced toxicity and improved efficacy.

Call for proposal

H2020-MSCA-IF-2019
See other projects for this call

Funding Scheme

MSCA-IF-EF-ST - Standard EF

Coordinator

INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ
Address
Avenida De Los Reyes Catolicos 2
28040 Madrid
Spain
Activity type
Research Organisations
EU contribution
€ 160 932,48